Condition

Cardiac Allograft Vasculopathy clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Cardiac Allograft Vasculopathy clinical trials that are recruiting, at sites in 2 countries (most in Canada (2), South Korea (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Cardiac Allograft Vasculopathy clinical trials

StudyPhaseWhereStatusRegistered
Using PET scans to monitor heart transplant patients for complications — Calgary, Alberta and 4 other locations Recruiting Oct 18, 2023
Investigating antiplatelet therapy to prevent complications in heart transplant patients Phase 3 Vancouver, British Columbia and 2 other locations Recruiting Feb 25, 2021
Evaluating microvascular function in heart transplant patients — Seoul Recruiting Jun 14, 2016

All recruiting trials (3)

Related topics

Heart Transplant

Quick answers

How many Cardiac Allograft Vasculopathy clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Canada (2 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.